Acadian Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $16.9M | Sell |
|
|||||
|
2024
Q2 | $18.3M | Buy |
|
|||||
|
2024
Q1 | $8.31M | Buy |
|
|||||
|
2023
Q4 | $2.19M | Sell |
|
|||||
|
2023
Q3 | $3.81M | Buy |
|
|||||
|
2023
Q2 | $253K | Sell |
|
|||||
|
2023
Q1 | $1.13M | Buy |
|
|||||
|
2022
Q4 | $37K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $979K | Sell |
|
|||||
|
2022
Q1 | $1.38M | Buy |
|
|||||
|
2021
Q4 | $576K | Sell |
|
|||||
|
2021
Q3 | $764K | Buy |
|
|||||
|
2021
Q2 | $684K | Hold |
|
|||||
|
2021
Q1 | $798K | Buy |
|
|||||
|
2020
Q4 | $591K | Sell |
|
|||||
|
2020
Q3 | $669K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $4.11M | Sell |
|
|||||
|
2019
Q3 | $7.98M | Sell |
|
|||||
|
2019
Q2 | $11.1M | Buy |
|
|||||
|
2019
Q1 | $6.17M | Buy |
|
|||||
|
2018
Q4 | $3.03M | Sell |
|
|||||
|
2018
Q3 | $18.6M | Buy |
|
|||||
|
2018
Q2 | $7.6M | Buy |
|
|||||
|
2018
Q1 | $190K | Buy |
|
|||||
|
2017
Q4 | $2K | Hold |
|
|||||
|
2017
Q3 | $2K | Sell |
|
|||||
|
2017
Q2 | $1.47M | Sell |
|
|||||
|
2017
Q1 | $2.82M | Sell |
|
|||||
|
2016
Q4 | $7.06M | Sell |
|
|||||
|
2016
Q3 | $10M | Sell |
|
|||||
|
2016
Q2 | $11.4M | Sell |
|
|||||
|
2016
Q1 | $16.1M | Sell |
|
|||||
|
2015
Q4 | $179M | Sell |
|
|||||
|
2015
Q3 | $236M | Sell |
|
|||||
|
2015
Q2 | $271M | Buy |
|
|||||
|
2015
Q1 | $229M | Sell |
|
|||||
|
2014
Q4 | $263M | Buy |
|
|||||
|
2014
Q3 | $220M | Buy |
|
|||||
|
2014
Q2 | $149M | Buy |
|
|||||
|
2014
Q1 | $24.2M | Buy |
|
|||||
|
2013
Q4 | $13.3M | Buy |
|
|||||
|
2013
Q3 | $9.74M | Sell |
|
|||||
|
2013
Q2 | $13.8M | Buy |
|